TF and cancer: The accumulation of porphyrin in cancer cells is due to π–π stacking between the π-conjugated structure of porphyrin and the aromatic amino acid residues of blood proteins (LDL, albumin, and transferrin), and to the activated endocytosis of these proteins facilitated by receptors activated in cancer cells [26].